Pivalic acid → HCID 178447383, compound
Reaction equation
Cl.Cl.[O:3]1[C:8]2=[CH:9][CH:10]=[CH:11][C:7]2=[CH:6][C:5]([CH:12]2[CH2:17][CH2:16][CH2:15][CH2:14][N:13]2[CH2:18][CH2:19][C@H:20]2[CH2:25][CH2:24][C@H:23]([NH2:26])[CH2:22][CH2:21]2)=[CH:4]1.[CH3:27][C:28]([CH3:33])([CH3:32])[C:29](O)=[O:30]>>[O:3]1[C:8]2=[CH:9][CH:10]=[CH:11][C:7]2=[CH:6][C:5]([CH:12]2[CH2:17][CH2:16][CH2:15][CH2:14][N:13]2[CH2:18][CH2:19][C@H:20]2[CH2:21][CH2:22][C@H:23]([NH:26][C:29](=[O:30])[C:28]([CH3:33])([CH3:32])[CH3:27])[CH2:24][CH2:25]2)=[CH:4]1Participants
3
Procedure
The title compound, white solid (76 mg, 74%), MS (ISP) m/z=411.5 [(M+H)+], mp 157° C., was prepared in accordance with the general method of example 1 from trans-4-[2-(4-benzofuran-3-yl-piperidin-1-yl)-ethyl]-cyclohexylamine dihydrochloride (intermediate A) (100 mg, 0.25 mmol) and 2,2-dimethyl-propionic acid.
Sources & evidence
- ORD record
- ord-b066311c985044a89bddca34944fde93
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08921397B2
Reaction notes
Loading…